+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis



Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis



Nephrology, Dialysis, Transplantation 15(Suppl. 5): 105-110




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010773699

Download citation: RISBibTeXText

PMID: 11073282

DOI: 10.1093/ndt/15.suppl_5.105


Related references

Myoneuropathy in patients with chronic renal failure treated with hemodialysis (HD) and intermittent peritoneal dialysis (IPD). I. Evaluation of myoelectric activity of selected skeletal muscles in patients with chronic renal failure treated with hemodialysis and intermittent peritoneal dialysis. Polskie Archiwum Medycyny Wewnetrznej 95(3): 229-236, 1996

Myoneuropathy in patients with chronic renal failure treated with hemodialysis (HD) and intermittent peritoneal dialysis (IPD). II. Sensory and motor nerve conduction velocity in patients with chronic renal failure treated with intermittent peritoneal dialysis and hemodialysis. Polskie Archiwum Medycyny Wewnetrznej 95(3): 237-244, 1996

The importance of oxidative stress in patients with chronic renal failure whose hypertension is treated with peritoneal dialysis. Cell Biochemistry and Function 29(3): 249-254, 2011

Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis. Przeglad Lekarski 47(10): 686-690, 1990

Recovery of renal function in end-stage renal failure--comparison between peritoneal dialysis and haemodialysis. Nephrology, Dialysis, Transplantation 24(9): 2825-2831, 2009

Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome. American Journal of Kidney Diseases 38(1): 165-168, 2001

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis. Peritoneal Dialysis International 27(2): 184-191, 2007

Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: A comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochemical & Biophysical Research Communications 308(3): 581-585, August 29, 2003

A first report Chronic renal failure, end-stage renal disease and peritoneal dialysis in Gitelmans syndrome. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 308A, 2001

Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis. Nephrology, Dialysis, Transplantation 2019, 2019

Risk of hemodialysis against peritoneal dialysis for chronic heart failure in patients with end-stage renal disease. International Journal of Cardiology 223: 360, 2016

The clinical outcome of end-stage renal disease patients who return to peritoneal dialysis after renal allograft failure. Transplantation Proceedings 45(8): 2949-2952, 2014

Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine. Clinical Science 73(S17): 41p.4-41p, 1987

Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Nephrology 21(8): 669-677, 2017

A comparison of CA 125 levels in patients with chronic liver disease and end-stage renal failure patients on continuous ambulatory peritoneal dialysis. Singapore Medical Journal 34(1): 88, 1993